Clinical manifestations and outcomes of EBV-related secondary hemophagocytic lymphohistiocytosis
In summary, our study firstly reported the clinical manifestations and outcomes of EBV-related sHLH following allo-HSCT in the largest cohort at present.
Authors
- Xiaojun Huang (ORCID: https://orcid.org/0000-0002-3976-6260)
- Xiaohui Zhang
- Xuying Pei (ORCID: https://orcid.org/0000-0003-1200-7763)
- Feng‐Rong Wang (ORCID: https://orcid.org/0000-0001-6778-1962)
- Xiao‐Dong Mo (ORCID: https://orcid.org/0000-0002-9881-7945)
- Dan Liu (ORCID: https://orcid.org/0000-0001-6791-1704)
- Yuhong Chen (ORCID: https://orcid.org/0000-0001-8840-4752)
- Yibin Wang (ORCID: https://orcid.org/0000-0003-0852-0767)
- Wei Han (ORCID: https://orcid.org/0009-0007-3976-0188)
- Yuqian Sun (ORCID: https://orcid.org/0000-0003-1856-2231)
- Huan Chen (ORCID: https://orcid.org/0000-0001-8648-1631)
- Lanping Xu
- Chen-Hua Yan
- Jingzhi Wang (ORCID: https://orcid.org/0000-0001-6439-9805)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking University People's Hospital (CN)
- Center for Life Sciences (CN)
Publication Details
- Journal
- Annals of Hematology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1007/s00277-025-06677-4
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Peking University